Alex Carvalho, general manager Pierre Fabre Brazil, provides insights into the rapidly ascending trajectory of the company in Brazil, its utmost commitment to oncology in the country, and Pierre Fabre’s eagerness to further investing in this strategic market. He also calls for a greater collaboration between all stakeholders to tackle the access conundrum in Brazil’s oncology field, including both the country’s private and public healthcare sectors.
Could you introduce to our international readers Pierre Fabre’s history in Brazil and the scope of its operations in the country?
"Market access is truly a priority in our organization, and our efforts encompass both our current portfolio as well as our upcoming oncology products."
